Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses
Yahoo Finance · 8 hours ago
Open | 43.56 |
High | 44.81 |
Low | 43.49 |
Mkt Cap | 90.69B |
P/E (TTM) | N/A |
Div & Yield | 2.40 & 5.50% |
Prev. Close | 43.67 |
52 Wk. Low | 43.33 |
52 Wk. High | 69.10 |
Related stocks
American pharmaceutical company
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 11.87B | 4.70% ▲ |
Net Income | -11.91B | - |
Diluted EPS | -4.40 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $1.70 | - |
Q1 2024 | -$4.44 | -$4.40 |
Q4 2023 | $1.43 | $1.59 |
S&P 500^GSPC | 5,214.08+26.41 (+0.51%) |
Dow 30^DJI | 39,387.76+331.36 (+0.85%) |
Nasdaq^IXIC | 16,346.26+43.46 (+0.27%) |
4.7500-1.25% | |
30.42-22.06% | |
18.01+13.13% |